Search Results 91-100 of 14432 for Antagonist
- Subjects with a history of an adverse reaction to CGRP (calcitonin gene-related peptide) antibodies or another CGRP antagonist (gepant). - Subjects with ...
Clinical Trials · Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in ...
Antagonism of innate immunity; Genome ... This cyclical adaptation mechanism leads to tissue-specific expression of an innate immunity antagonist ...
If you are taking anticoagulant medicine (blood thinners), the amount of vitamin K in your diet may affect how well these medicines work. Your doctor or health ...
The reduction in mortality and morbidity in CHF by pharmacologic neurohumoral antagonists such as beta-receptor inhibitor and angiotensin II-converting ...
Gattone led to several clinical trials of tolvaptan, a V2 receptor antagonist. These trials include a large phase 3:4 clinical trial and have already led to ...
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor. ACS Med Chem Lett. 2019 Jan 10; 10 ...
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...
... Antagonist, in Subjects with Idiopathic Pulmonary Fibrosis with Persistent Cough A Study of AF-219 in Subjects with Idiopathic Pulmonary Fibrosis with ...
... Antagonist Buprenorphine During Acute Pain and Surgery. Mayo Clin Proc. 2020 ... A Practical Approach for the Management of the Mixed Opioid Agonist-Antagonist ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.